Zagaliotis, P.; Petrou, A.; Mystridis, G.A.; Geronikaki, A.; Vizirianakis, I.S.; Walsh, T.J.
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. Int. J. Mol. Sci. 2022, 23, 8006.
https://doi.org/10.3390/ijms23148006
AMA Style
Zagaliotis P, Petrou A, Mystridis GA, Geronikaki A, Vizirianakis IS, Walsh TJ.
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences. 2022; 23(14):8006.
https://doi.org/10.3390/ijms23148006
Chicago/Turabian Style
Zagaliotis, Panagiotis, Anthi Petrou, George A. Mystridis, Athina Geronikaki, Ioannis S. Vizirianakis, and Thomas J. Walsh.
2022. "Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling" International Journal of Molecular Sciences 23, no. 14: 8006.
https://doi.org/10.3390/ijms23148006
APA Style
Zagaliotis, P., Petrou, A., Mystridis, G. A., Geronikaki, A., Vizirianakis, I. S., & Walsh, T. J.
(2022). Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences, 23(14), 8006.
https://doi.org/10.3390/ijms23148006